HIGHLIGHTS
- who: Rima El-Dirany et al. from the ISTUN Institute of Tropical Health, Department of Microbiology and Parasitology, IdiSNA (Navarra Institute for Health Research), University of Navarra, c/Irunlarrea, Pamplona, Navarra, Spain have published the article: Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of 25/02/2016
- what: In this study the approach of repurposing AMPs as antileishmanial drugs was applied. In the present study, the effects of both AMPs 19-2.5 and 19 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.